-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Background: Yiqi Fumai freeze-dried injection (YQFM) is derived from the classic ancient prescription Shengmai San , composed of red ginseng, Ophiopogon japonicus and Schisandra chinensis , and is clinically used in the treatment of cardiovascular and cerebrovascular diseases
.
ATG9A is the only transmembrane protein responsible for transporting membrane components to autophagosomes.
Yiqi Fumai Freeze-dried Injection (YQFM) Yiqi Fumai Freeze-dried Injection (YQFM) Red Ginseng, Ophiopogon and Schisandra 3 Chinese Medicine Red Ginseng, Ophiopogon and Schisandra 3 Chinese Medicine Cardiovascular and Cerebrovascular Diseases Cardiovascular and Cerebrovascular Diseases ATG9A ATG9A NMMHC IIA NMMHC IIA oxygen-glucose deprivation and reoxidation (OGD/R) oxygen-glucose deprivation and reoxidation (OGD/R)
Objective: To evaluate whether YQFM can form autophagosomes by inhibiting the interaction of NMMHC IIA-actin-ATG9A, which has a neuroprotective effect on cerebral ischemia-reperfusion injury
.
Methods: The neurological deficit, infarct volume and histopathological changes of middle cerebral artery occlusion/reperfusion (MCAO/R) mice were detected to observe the protective effect of YQFM on brain nerves .
NMMHC IIA-actin-ATG9A by interaction colocalization immunofluorescence , immunoprecipitation determined .
In vitro experiments used rat pheochromocytoma (PC12) cells to simulate neurons after oxygen-glucose deprivation/reoxidation (OGD/R) .
Results: The neuroprotection of different doses of YQFM (0.
336, 0.
671, 1.
342 g/kg) and positive control drug nimodipine (5 mg/kg) on MCAO mice was evaluated by the area of infarct area and the score of neurological deficit 24h after reperfusion.
Histopathology, morphology, and neurological deficit scores indicate that YQFM has neuroprotective effects on MCAO/R mice, which may be related to autophagy
.
Western blotting results of autophagy-specific marker proteins p62 and LC3B showed that MCAO/R damage was reduced after YQFM treatment
The results of immunofluorescence staining showed that YQFM can significantly inhibit the translocation of ATG9A induced by MCAO/R and play a protective role
.
Fluorescence colocalization results show that YQFM regulates the interaction of NMMHC IIA-F-actin-ATG9A, inhibits ATG9A translocation in MCAO/R mice, and reduces cerebral ischemia/reperfusion injury
Immunofluorescence staining immunofluorescence staining
Using PC12 cells to simulate neurons in vitro, the results show that YQFM (400 μg/ml) can significantly inhibit OGD/R-induced excessive autophagy in PC12 cells by interfering with the translocation of ATG9A
.
In addition, the RNAi of NMMHC IIA attenuates the NMMHC IIA-F-actin-mediated ATG9A transport, thereby weakening the in vitro neuroprotective activity of YQFM
Conclusion: YQFM inhibits excessive autophagy and exerts neuroprotective effects by interfering with NMMHC IIA-actin-mediated ATG9A translocation .
It is a promising drug for the treatment of brain I/R injury
.
The results of this study provide experimental evidence for YQFM to prevent and treat brain I/R, but the importance of various components in YQFM is still unclear, and further research is needed
Inhibition of excessive autophagy Inhibition of excessive autophagy
Literature source:
Literature source:Su, L.
Su, L.
, Liu, Y.
, Ma, H.
, et al.
(2021).
YiQiFuMai lyophilized injection attenuates cerebral ischemic injury with inhibition of neuronal autophagy through intervention in the NMMHC IIA-actin-ATG9A interaction.
Phytomedicine: international journal of phytotherapy and phytopharmacology, 95, 153882.
Advance online publication.
https://doi.
org/10.
1016/j.
phymed.
2021.
153882 Leave a message here